Anna Honko, PhD
Clinical Instructor
Boston University School of Medicine
Dept of Microbiology

PhD, Wake Forest University




Anna Honko, PhD recently joined Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) as a Research Associate Professor. In the Nonclinical Studies Unit, she’ll be directing well-documented, Animal Rule and GLP studies to advance anti-viral medical countermeasure development. Dr. Honko's background is in immunology and vaccine development, with a later emphasis in biothreat and emerging infectious diseases. She has a focus on regulated studies as well a passion for radiotelemetry monitoring.

Faculty
Boston University
National Emerging Infectious Disease Lab



2014 Department of Army Civilian Performance Award
2013 Army Certificate of Achievement Award: Filovirus Euthanasia Criteria IPT
2011 Army Certificate of Achievement Award: Ebola virus Kikwit stock IPT
2011 Department of Army Civilian Performance Award
2006-2010 National Research Council post-doctoral training fellowship
2005 Alumni Student travel award

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021 Jul 10.View Related Profiles. PMID: 34245255
     
  2. Atyeo C, Slein MD, Fischinger S, Burke J, Schäfer A, Leist SR, Kuzmina NA, Mire C, Honko A, Johnson R, Storm N, Bernett M, Tong P, Zuo T, Lin J, Zuiani A, Linde C, Suscovich T, Wesemann DR, Griffiths A, Desjarlais JR, Juelg BD, Goudsmit J, Bukreyev A, Baric R, Alter G. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight. 2021 01 11; 6(1).View Related Profiles. PMID: 33427208; PMCID: PMC7821590; DOI: 10.1172/jci.insight.143129;
     
  3. Zabaleta N, Dai W, Bhatt U, Chichester JA, Estelien R, Sanmiguel J, Michalson KT, Diop C, Maciorowski D, Qi W, Hudspeth E, Cucalon A, Dyer CD, Pampena MB, Knox JJ, LaRocque RC, Charles RC, Li D, Kim M, Sheridan A, Storm N, Johnson RI, Feldman J, Hauser BM, Ryan A, Kobayashi DT, Chauhan R, McGlynn M, Ryan ET, Schmidt AG, Price B, Honko A, Griffiths A, Yaghmour S, Hodge R, Betts MR, Freeman MW, Wilson JM, Vandenberghe LH. Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates. bioRxiv. 2021 Jan 05.View Related Profiles. PMID: 33442684; PMCID: PMC7805441; DOI: 10.1101/2021.01.05.422952;
     
  4. Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH, Fang RH, Gao W, Griffiths A, Zhang L. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Lett. 2020 07 08; 20(7):5570-5574.View Related Profiles. PMID: 32551679; PMCID: PMC7301960; DOI: 10.1021/acs.nanolett.0c02278;
     
  5. Speranza E, Caballero I, Honko AN, Johnson JC, Bohannon JK, Evans DeWald L, Gerhardt DM, Sword J, Hensley LE, Bennett RS, Connor JH. Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection. mBio. 2020 06 16; 11(3).View Related Profiles. PMID: 32546624; PMCID: PMC7298714; DOI: 10.1128/mBio.01157-20;
     
  6. Downs IL, Shaia CI, Zeng X, Johnson JC, Hensley L, Saunders DL, Rossi F, Cashman KA, Esham HL, Gregory MK, Pratt WD, Trefry JC, Everson KA, Larcom CB, Okwesili AC, Cardile AP, Honko A. Natural History of Aerosol Induced Lassa Fever in Non-Human Primates. Viruses. 2020 05 29; 12(6). PMID: 32485952; PMCID: PMC7354473; DOI: 10.3390/v12060593;
     
  7. DeWald LE, Johnson JC, Gerhardt DM, Torzewski LM, Postnikova E, Honko AN, Janosko K, Huzella L, Dowling WE, Eakin AE, Osborn BL, Gahagen J, Tang L, Green CE, Mirsalis JC, Holbrook MR, Jahrling PB, Dyall J, Hensley LE. In Vivo Activity of Amodiaquine against Ebola Virus Infection. Sci Rep. 2019 12 27; 9(1):20199. PMID: 31882748; PMCID: PMC6934550; DOI: 10.1038/s41598-019-56481-0;
     
  8. Liu J, Coffin KM, Johnston SC, Babka AM, Bell TM, Long SY, Honko AN, Kuhn JH, Zeng X. Nipah virus persists in the brains of nonhuman primate survivors. JCI Insight. 2019 07 25; 4(14). PMID: 31341108; PMCID: PMC6675545; DOI: 10.1172/jci.insight.129629;
     
  9. Sebba D, Lastovich AG, Kuroda M, Fallows E, Johnson J, Ahouidi A, Honko AN, Fu H, Nielson R, Carruthers E, Diédhiou C, Ahmadou D, Soropogui B, Ruedas J, Peters K, Bartkowiak M, Magassouba N, Mboup S, Ben Amor Y, Connor JH, Weidemaier K. A point-of-care diagnostic for differentiating Ebola from endemic febrile diseases. Sci Transl Med. 2018 12 12; 10(471).View Related Profiles. PMID: 30541788
     
  10. Cross RW, Speranza E, Borisevich V, Widen SG, Wood TG, Shim RS, Adams RD, Gerhardt DM, Bennett RS, Honko AN, Johnson JC, Hensley LE, Geisbert TW, Connor JH. Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans. J Infect Dis. 2018 11 22; 218(suppl_5):S486-S495.View Related Profiles. PMID: 30476250; PMCID: PMC6249602; DOI: 10.1093/infdis/jiy455;
     
Showing 10 of 63 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 63 publications over 17 distinct years, with a maximum of 9 publications in 2014

YearPublications
20031
20041
20051
20061
20081
20104
20114
20126
20134
20149
20156
20168
20172
20187
20192
20203
20213
Contact for Mentoring:
Honko's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department